Journals / Retina-Vitreus / 2018 / Cilt: 27 - Sayı: 3

Management of Inadvertently Intralenticular Injected Dexamethasone Implants

Yanlışlıkla İntralentiküler Enjekte Edilen Deksametazon İmplantlarının Yönetimi

Pages
280–282
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

With proper management, it is possible to remove the cataract and preserve the implant in this rare complication of dexamethasone implant use.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Inadvertent intra-lenticular injection is a rare complication of dexamethasone implant injection.
📊
Key Findings & Data:Two patients, one with diabetic macular edema and the other with branch retinal vein occlusion had admitted to our clinic with the complaint of a decrease in visual acuity following in- travitreal dexamethasone implant injection.
💡
Conclusion & Impact:With proper management, it is possible to remove the cataract and preserve the implant in this rare complication of dexamethasone implant use.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Inadvertent intra-lenticular injection is a rare complication of dexamethasone implant injection. Herein clinical management of two inadvertently intra-lenticular injected dexamethasone implant cases are described. Two patients, one with diabetic macular edema and the other with branch retinal vein occlusion had admitted to our clinic with the complaint of a decrease in visual acuity following in- travitreal dexamethasone implant injection. Visual acuities were at the level of 0.05 and counting fi ngers at 1 meter respectively. The implants were localized in the posterior epinucleus of the lens along with cataract. Removal of the cataracts with preservation of the dexamethasone implants was decided. The cataracts were removed with phacoemulsifi cation; intra-lenticular dexamethasone implants were successfully repositioned into the vitreous cavity through the defects in the posterior capsules. The decrease in foveal thickness was continued in one of the cases but macular edema recurred in the other. With proper management, it is possible to remove the cataract and preserve the implant in this rare complication of dexamethasone implant use.

Özet

Yanlışlıkla intralentiküler enjeksiyon deksametazon implant enjeksiyonunun nadir görülen bir komplikasyonudur. Bu iki olgu sunu- munda yanlışlıkla intralentiküler enjekte edilen deksametazon implantların yönetimi ve klinik seyri sunuldu. Diyabetik maküla ödemi olan bir hasta ve retinal ven dal tıkanıklığı bulunan bir diğer hasta kliniğimize deksametazon implant enjeksiyonu sonrası görme azal- ması şikayetiyle başvurdu. Görme keskinlikleri sırasıyla 0.05 ve 1 metreden parmak sayar düzeyinde olan hastaların biyomikroskopik incelemesinde lenslerin arka epinükleusları içerisine gömülü deksametazon implantları tespit edildi. İmplantların korunarak lenslerin alınmasına karar verildi. Kataraktlı lensler fakoemülsifi kasyon yöntemi ile temizlendi, deksametazon implantları korunarak kapsül yüzeyindeki defektlerden başarılı bir şekilde vitreus kavitesine yönlendirildi. Santral maküla kalınlığı cerrahi sonrasında vakaların bir tanesinde azalmaya devam ederken diğerinde artış gösterdi. Nadir görülen bu komplikasyonda doğru yaklaşımla kataraktlı lensin alınarak implantın korunabildiği görüldü.

🔖

Cite This Article

KARACA, Ç., MİRZA, E., ÖNER, A. (2018). Management of Inadvertently Intralenticular Injected Dexamethasone Implants. Retina-Vitreus, Cilt: 27 - Sayı: 3, 280–282. https://ajindex.com/articles/304878

References (6)

  1. London NJ, Chiang A, Haller JA. The dexamethasone drug de- livery system: indications and evidence. Advances in therapy. 2011;28(5):351-66.
  2. Kiddee W, Trope GE, Sheng L, et al. Intraocular pressure monito- ring post intravitreal steroids: A systematic review. Survey of opht- halmology. 2013;58(4):291-310.
  3. Marchino T, Vela JI, Bassaganyas F, Sanchez S, Buil JA. Acute-On- set Endophthalmitis Caused by Alloiococcus otitidis following a Dexamethasone Intravitreal Implant. Case reports in ophthalmo- logy. 2013;4(1):37-41. Howard GV. Principles of Nuclear Phacoemulsifi cation. In: Roger SR, ed. Cataract Surgery. 2nd Edition ed. Philadelphia, Pennsylva- nia: Saunders; 2004:156-7.
  4. Chhabra R, Kopsidas K, Mahmood S. Accidental insertion of dexa- methasone implant into the crystalline lens[mdash]12 months fol- low-up. Eye. 2014;28(5):624-5.
  5. Chalioulias K, Muqit MMK. Vitreoretinal surgery for inadvertent intralenticular Ozurdex implant. Eye. 2014;28(12):1523-4.
  6. Bakri SJ, Omar AF, Iezzi R, Kapoor KG. Evaluation of multiple dexamethasone intravitreal implants in patients with macular ede- ma associated with retinal vein occlusion. Retina (Philadelphia, Pa.). 2015.